Double encapsulated oral transplant of fecal microbiota
Sponsors
Assistance Publique Hopitaux De Paris
Conditions
Adults Non Diabete Remission (NDR) Type 2 Diabete (T2D) patients 1 to 5 years after bariatric surgeryCrohn’s diseasePatients colonized with MDR-GNBPrimary Sclerosing CholangitisSevere Irritable Bowel Syndrome (IBS)Ulcerative Colitis
Phase 2
T-FORE - Pilot study of a new technique of Oral Fecal Transplantation using frozen stool capsules for the maintenance treatment of pediatric Ulcerative Colitis (UC)
Not yet recruitingCTIS2024-518044-20-00
Target: 30Updated: 2025-08-22
Fecal microbiota transplantation for primary sclerosing cholangitis - randomized study versus sham transplantation (FMT-SCLER).
Not yet recruitingCTIS2023-505469-95-00
Target: 72Updated: 2025-12-02
Phase 3
ICEBOAT. A prospective, multi-center, double blind randomized trial of fecal microbiota transplantation (FMT) delivered by capsule versus placebo in severe irritable bowel syndrome (IBS)
Not yet recruitingCTIS2024-516099-13-00
Target: 150Updated: 2025-05-21
Fecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawal (MIRACLE)
RecruitingCTIS2024-511822-30-00
Start: 2021-09-22Target: 350Updated: 2025-07-15
Diabete RemIssion using Fecal TransfER post bariatric surgery (DRIFTER)
RecruitingCTIS2024-511870-65-00
Start: 2024-01-16Target: 94Updated: 2024-11-06
FECES - Fecal transplantation to Eradicate Colonizing Emergent Superbugs
Not yet recruitingCTIS2024-516393-29-00
Target: 299Updated: 2025-05-09